FierceBiotech: ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior to Enoxaparin in the Preve ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior to Enoxaparin in the Prevention of Venous Thromboembolism Following Knee Replacement Surgery Phase ... ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior to Enoxaparin in the Preve The FDA is recommending that healthcare professionals carefully time the spinal catheter placement and removal in patients taking anticoagulants (eg, enoxaparin), and delay dosing of anticoagulants ... Insurancenewsnet.com: Lieff Cabraser Heimann & Bernstein, LLP Announce a Notice of Settlement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin Lieff Cabraser Heimann & Bernstein, LLP Announce a Notice of Settlement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin (Paris, France) — A new-point-of care test that can be used in the cath lab to monitor anticoagulation levels of enoxaparin (Lovenox, Sanofi-Aventis) has been shown to give reliable ...
The EXPRESS trial is part of a larger program of investigation now under way examining the potential advantages of the new anticoagulant. Ximelagatran is an oral direct thrombin inhibitor, which is ...
